| 13:30-14:00 |
התכנסות ורישום, ארוחה קלה |
| 14:00-14:05 |
פתיחה וברכות
פרופ׳ עמית אסא, יו"ר האיגוד |
| 14:05-14:15 |
תקציב ופעילויות האיגוד
ד״ר פיראס רינאוי |
14:15-15:25
|
מושב ראשון - כבד
יו״ר: ד״ר יעל מוזר-גלזברג שניידר, ד״ר סמאח טאטור העמק
|
| 14:15-14:25 |
USP53-Related Progressive Familial Intrahepatic Cholestasis: Case series and review of literature
Gadi Howard, Soroka Medical Center |
| 14:25-14:35 |
Identification of hepatocyte immune response in children with Autoimmune Hepatitis by human plasma cfChIP-seq
Eyal Shteyer, Shaare Zedek |
| 14:35-14:45 |
Familial Hypobetalipoproteinemia in pediatric patients with fatty liver- an under-recognized cause?
Nurit Loberman Nachum, Sheba |
| 14:45-14:55 |
Metabolic syndrome prevalence among teenagers post liver transplantation
Tal Cozacov, Schneider |
| 14:55-15:05 |
Fetal Hepatic Lesions: Prenatal Characteristics and Postnatal Outcomes – A retrospective analysis
Sophia Heiman, Sheba |
| 15:05-15:15 |
Human biliary atresia extra-hepatic cholangiocyte organoids express high ER and oxidative stress changes in drug metabolism and cell-to-cell junction alterations
Orit Waisbourd-Zinman, Schneider |
| 15:15-15:25 |
An innocent bystander or a predisposing culprit? Kidney injury following pediatric liver transplantation
Hadas Alfandari, Schneider |
| 15:25-15:50 |
הרצאת מרצה אורחת:
Nutrition support of children with complex medical needs
Marialena Mouzaki, Cincinnati Children's Medical Center
|
| 15:50-16:05 |
שיפור תהליך הגיוס של מתנדבים לצה״ל
ד״ר עינת ברלא, צה"ל וד״ר הדס אלפנדרי, המרכז הרפואי שניידר |
| 16:05-16:30 |
הפסקה |
16:30-18:40
|
מושב שני IBD
יו״ר – ד״ר חני טאף אסותא אשדוד, ד״ר רפי לב ציון שערי צדק
|
| 16:30-16:40 |
Limited Willingness to Switch from Intravenous to Subcutaneous Treatment in Children with IBD
Nimrod Ophir, Asaf Harofe |
| 16:40-16:50 |
Diet-omics in the Study of Urban and Rural Crohn disease Evolution SOURCE cohort
Yael Haberman, Sheba |
| 16:50-17:00 |
Upadacitinib for induction of remission in pediatric Crohn's disease: An international multicenter study
Anat Yerushalmy-Feler, Dana-Dwek |
| 17:00-17:10 |
Chronic Recurrent Multifocal Osteomyelitis associated with Paediatric Inflammatory Bowel disease: A Multi-Center Retrospective Study from the Paediatric IBD Porto Group of ESPGHAN
Manar Matar, Schneider |
| 17:10-17:20 |
The Safety and Efficacy of Adalimumab 80mg Weekly as Maintenance Therapy in Pediatric Crohn's Disease
Eyal Cohen-Sela, Schneider |
| 17:20-17:30 |
Burden of depression and anxiety among patients with pediatric-onset Inflammatory Bowel Disease: A nationwide study from the epi-IIRN
Firas Rinawi, Emek Medical Center |
| 17:30-17:40 |
Efficacy and safety of risankizumab in children with Crohn's disease: A preliminary report
Amit Assa, Shaare Zedek |
| 17:40-17:50 |
Maintenance-phase serum anti-TNF levels are not associated with mucosal healing in pediatric Crohn's disease
Rinat Grabovski, Schneider |
| 17:50-18:00 |
Effectiveness and safety of adalimumab in patients with very early-onset inflammatory bowel disease: A retrospective study on behalf of the Porto IBD Working Group of ESPGHAN
Dror Shoval, Schneider |
| 18:00-18:10 |
Adipokines profile and disease activity in pediatric Crohn's disease
Ramit Magen Rimon, Rambam |
| 18:10-18:20 |
Safety and effectiveness of Indigo Naturalis for induction of remission in children with mild to moderate ulcerative Colitis: a prospective open-label trial
Yogev Dotan, Shaare Zedek |
| 18:20-18:30 |
Differences in disease characteristics and treatment exposures between pediatric and adult-onset inflammatory bowel disease using a registry-based cohort
Maya Granot, Sheba |
| 18:30-18:40 |
Positive anti-Saccharomyces cerevisiae antibodies do not affect clinical outcomes in pediatric patients with Crohn's disease treated with anti-TNF therapy
Daniel Ling, Schneider |
| 18:40-19:10 |
הרצאת מרצה אורחת – תנו ל ChatGPT לעבוד בשבילכם, מינוף כלי AI כעוזרי מחקר
ד״ר מרים ספראי, שיבא |